Table 2 |
||||
|
Hemodynamic data for 10 men consuming Meltdown® and placebo in a randomized cross-over design. |
||||
|
Variable |
0 min |
30 min |
60 min |
90 min |
|
|
||||
|
Heart rate (bpm) Meltdown® |
59 ± 3 |
63 ± 2 |
62 ± 2 |
63 ± 2 |
|
Heart rate (bpm) Placebo |
59 ± 3 |
60 ± 3 |
62 ± 3 |
60 ± 3 |
|
Systolic Blood Pressure (mmHg) Meltdown® * |
117 ± 2 |
122 ± 3 |
123 ± 2 |
122 ± 3 |
|
Systolic Blood Pressure (mmHg) Placebo |
118 ± 2 |
118 ± 2 |
117 ± 1 |
116 ± 1 |
|
Diastolic Blood Pressure (mmHg) Meltdown® |
72 ± 1 |
71 ± 2 |
72 ± 2 |
70 ± 2 |
|
Diastolic Blood Pressure (mmHg) Placebo |
72 ± 1 |
72 ± 2 |
71 ± 1 |
71 ± 1 |
|
|
||||
|
Data are mean ± SEM. *Condition effect; higher systolic blood pressure for Meltdown® compared to placebo (p = 0.04). No other statistically significant effects noted (p > 0.05). |
||||
|
Bloomer et al. Journal of the International Society of Sports Nutrition 2009 6:4 doi:10.1186/1550-2783-6-4 |
||||
